4D Molecular Therapeutics In

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$10.14

+0.21 (+2.11%)

As of May 10, 10:23 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 82%

Hold 3 18%

Sell 0 0%

Price Target

Analyst Price Target +108.2% upside

Low Target $12.84

Average Target $21.11

High Target $26.25

Current Price $10.14

Current
$10.14

Target
$21.11

$12.84 $21.11 avg $26.25

Scenario Analysis

Bear Case

$12.84

26.6%

Low target

Base Case

$21.11

+108.2%

Avg target

Bull Case

$26.25

+158.9%

High target

Risk/Reward

6.0x

Highly favorable

Price in Context

52-Week High

$12.34

-17.8% from high

52-Week Low

$3.00

+238.0% from low

Target vs 52W High

$21.11

+71.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%